Clinical Trials | Virtual Congress | Novartis HCP

This site is for health care professionals only.

Featured Congresses

2022 ASCO Annual Meeting

EHA 2022 Virtual Congress

WCLC 2022

ESMO Congress 2022

EANM 2022 Congress

SABCS 2022

2022 ASH Annual Meeting

.atomic-select.jsAtomicSelect { display: none; }

.atomic-navigation-links__li._lvl1:hover .atomic-navigation-links__ul._lvl2 { display: block; } .atomic-navigation-links__li._lvl1:hover .atomic-navigation-links__plus-expand-icon { display: none; } .atomic-navigation-links__li._lvl1:hover .atomic-navigation-links__minus-expand-icon { display: block; }

Pipeline Navigator

Pipeline Navigator

Clinical trials are at the heart of our work to bring innovative medicines to people with cancer and blood disorders.

Solid Tumors

Solid Tumors

Breast & Women's Cancer

Gastrointestinal (GI) Cancers

Lung Cancer

Melanoma

Neuroendocrine Tumors (NET) & Other Radiosensitive Tumors

Prostate Cancer

Malignant Hematology

Malignant Hematology

Chimeric Antigen Receptor T-Cell Therapy (CAR-T)

Chronic Myeloid Leukemia (CML)

Myelodysplastic Syndromes (MDS) & Acute Myeloid Leukemia (AML)

Myeloproliferative Neoplasms (MPN) & Graft versus Host Disease (GvHD)

Non-malignant Hematology

Non-malignant Hematology

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Sickle Cell Disease

Rare Diseases

Rare Diseases

PIK3CA-Related Overgrowth Spectrum (PROS)

Pipeline Navigator

Explore our bold pipeline to learn how we are reimagining cancer and blood disorders

Novartis

.lazy { display: none; }

Use of website is governed by the Terms of Use and Privacy Policy.

Copyright © 2022 Novartis Pharmaceuticals Corporation. All rights reserved.

10/22 121333-3